IOBT Q2 2025 Earnings — IO Biotech, Inc. Revenue & Financial Results | Market Cap Arena

IOBTIO Biotech, Inc.

$21M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$234,000

Operating Income

-$23M

Net Income

-$26M

EPS (Diluted)

$-0.40

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$42M

Total Liabilities

$41M

Stockholders' Equity

$2M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$234,000	-$214,000	-9.3%
Operating Income	-$23M	-$22M	-7.6%
Net Income	-$26M	-$21M	-26.7%